申请人:Rgenix, Inc.
公开号:US20170050924A1
公开(公告)日:2017-02-23
This invention relates to compounds that inhibit creatine transport and/or creatine kinase, pharmaceutical compositions including such compounds, and methods of utilizing such compounds and compositions for the treatment of cancer.